AbbVie
ABBV
#30
Rank
S$413.24 B
Marketcap
$233.85
Share price
0.10%
Change (1 day)
13.81%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Market capitalization of AbbVie (ABBV)

Market cap: S$413.24 Billion

As of December 2024 AbbVie has a market cap of S$413.24 Billion. This makes AbbVie the world's 30th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of AbbVie from 2012 to 2024

End of year Market Cap

Year Marketcap Change
2024S$413.24 B14.36%
2023S$361.35 B-5.69%
2022S$383.14 B18.4%
2021S$323.60 B29.31%
2020S$250.26 B41.76%
2019S$176.53 B-5.22%
2018S$186.25 B-9.8%
2017S$206.49 B40.21%
2016S$147.28 B9.18%
2015S$134.90 B-1.96%
2014S$137.60 B29.56%
2013S$106.20 B60.91%
2012S$66.00 B

End of Day market cap according to different sources

On Dec 15th, 2024 the market cap of AbbVie was reported to be:

S$413.24 Billion
by Yahoo Finance info icon info icon
S$416.06 Billion
by CompaniesMarketCap info icon info icon
S$413.24 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
S$195.53 B-52.68%๐Ÿ‡บ๐Ÿ‡ธ USA
S$152.59 B-63.07%๐Ÿ‡บ๐Ÿ‡ธ USA
S$957.23 B 131.64%๐Ÿ‡บ๐Ÿ‡ธ USA
S$196.21 B-52.52%๐Ÿ‡บ๐Ÿ‡ธ USA
S$154.41 B-62.63%๐Ÿ‡บ๐Ÿ‡ธ USA
S$29.48 B-92.86%๐Ÿ‡บ๐Ÿ‡ธ USA
S$93.72 B-77.32%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$282.10 B-31.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$17.30 B-95.81%๐Ÿ‡บ๐Ÿ‡ธ USA